Concepedia

Mona Mohammadhosseini

MM

Statistics

Publications

2

Citations

32

H-Index

2

Active since

2024

Affiliations

Oregon Health & Science University(Current)

Mona Mohammadhosseini is an author at Oregon Health & Science University specializing in acute myeloid leukemia therapy, mek signaling, and therapeutic resistance mechanisms.

ORCID

Publications per year

2024–2025

2

Publications

2

Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia

Rucha V. Modak, Katia G. de Oliveira Rebola, John McClatchy et al. · Clinical Cancer Research · 2024 · 17 citations · Full text

, , +17

Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in <i>RUNX1</i> -familial platelet disorder

Mona Mohammadhosseini, Trevor Enright, Adam DuVall et al. · Science Translational Medicine · 2025 · 15 citations · Full text

, , +17

1–2 of 2